TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / PanTheryx Stock

PanTheryx Stock

PanTheryx.comHealthcare / BioTech & PharmaFounded: 2007Funding to Date: $137.56MM

PanTheryx is a nutrition and biotechnology company committed to the global commercialization of bovine colostrum-based health and wellness solutions.

Buy or sell PanTheryx stockLearn more about PanTheryx IPO

Register To Buy and Sell Shares

For more details on financing and valuation for PanTheryx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access PanTheryx’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like PanTheryx.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Wes Parris
Chief Executive Officer
Bimla Starzl
Co-Founder
Amy Gibbs
Controller
James Hau
Chief Financial Officer
Mark Grabowsky
Chief Medical Officer

Board Members

David Cogut
Pegasus Capital Advisors
Craig Cogut JD
Pegasus Capital Advisors
Mark Braman
PanTheryx
Peter Vitulli

Frequently Asked Questions About PanTheryx’s Stock

plusminus
Can you buy PanTheryx’s stock?
PanTheryx is not publicly traded on NYSE or NASDAQ in the U.S. To buy PanTheryx’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell PanTheryx’s stock?
Yes, you can sell stock of a private company like PanTheryx. Forge can help you sell your PanTheryx stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is PanTheryx’s stock price?
PanTheryx is a privately held company and therefore does not have a public stock price. However, you may access PanTheryx’s private market stock price with Forge Data.
plusminus
What is PanTheryx’s stock ticker symbol?
PanTheryx does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like PanTheryx in the BioTech & Pharma sector

Egenesis

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$387.57MM

Colossal Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B

Prime Medicine

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.23B

ADARx Pharmaceuticals

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$827.77MM

Altos Labs

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B

Tempus

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.7B

Pendulum Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM

Cytonics

Sector
Healthcare / BioTech & Pharma
 
 

AI Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$110MM

News Highlights

02/25/2017
5 Questions with CEO of Boulder's PanTheryx
With two acquisitions, a Boulder company has become the world's largest manufacturer of a rare, nutrient-rich substance: bovine colostrum.
02/14/2017
PanTheryx acquires 2 colostrum processing companies – BizWest
BOULDER — PanTheryx Inc., a Boulder-based life-science company, announced on Tuesday that it has acquired two companies that process colostrum harvested from cows, a key ingredient in the company’s flagship nutritional product, DiaResQ.
04/26/2016
Passport Health and PanTheryx Announce the Availability of DiaResQ, a New Option for Relieving Traveler’s Diarrhea
SCOTTSDALE, Ariz. & BOULDER, Colo.--(BUSINESS WIRE)--Instead of just waiting for symptoms to go away, global travelers now have a new way to relieve diarrhea, thanks to a partnership announced today by Passport Health and PanTheryx, Inc.

Trending Companies

Frequently Asked Questions

Updated on: Apr 25, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.